Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikołaj Spytek

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Biometrical Journal. Biometrische Zeitschrift|October 31, 2025
Interpretable Machine Learning for Survival AnalysisSophie Hanna Langbein, Mateusz Krzyziński, Mikołaj Spytek, et al.
Bioinformatics (Oxford, England)|December 1, 2023
survex: an R package for explaining machine learning survival modelsMikołaj Spytek, Mateusz Krzyziński, Sophie Hanna Langbein, et al.
The British Journal of Ophthalmology|September 21, 2023
Ki67 is a better marker than PRAME in risk stratification of BAP1-positive and BAP1-loss uveal melanomasPiotr Donizy, Mikołaj Spytek, Mateusz Krzyziński, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Biometrical Journal. Biometrische Zeitschrift|October 31, 2025
Interpretable Machine Learning for Survival AnalysisSophie Hanna Langbein, Mateusz Krzyziński, Mikołaj Spytek, et al.
Bioinformatics (Oxford, England)|December 1, 2023
survex: an R package for explaining machine learning survival modelsMikołaj Spytek, Mateusz Krzyziński, Sophie Hanna Langbein, et al.
The British Journal of Ophthalmology|September 21, 2023
Ki67 is a better marker than PRAME in risk stratification of BAP1-positive and BAP1-loss uveal melanomasPiotr Donizy, Mikołaj Spytek, Mateusz Krzyziński, et al.
Pageof 1